Zoetis Inc. (ZTS)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$79.11-2.08%As of 2026-11-22 · USD
Last session low $78.80Last session high $83.08
52-week low $68.7752-week high $132.49
Market cap
$32.14B
Sector
Healthcare
P/E (TTM)
13.5x
Dividend yield
2.68%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)53.5In the neutral range (30 to 70)
MACD (12, 26, 9)1.54Below its signal line (1.85); histogram -0.31
Bollinger %B (20, 2)21%Inside the bands (76.95 to 87.39)
SMA 2082.17Price is 3.7% below
SMA 5077.26Price is 2.4% above
SMA 20090.45Price is 12.5% below
ATR (20)3.29% of priceAverage true range per day
52-week position16%In the lower part of the 68.77 to 132.49 range

About Zoetis Inc.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Latest fiscal yearEnded 2025-12-31: revenue of $9.47B and an operating margin of 38.0%.

More in Drug Manufacturers - Specialty & Generic